Key result
Serum pro-BNP levels were higher in heart transplant patients with acute rejection compared to those without rejection, and levels increased with advanced rejection grades.
Why the study?
Cardiac transplantation is the gold standard for end-stage heart failure, but acute rejection remains the most important factor affecting its success.
Are elevated serum pro-BNP levels and non-invasive parameters associated with acute rejection in patients who undergo cardiac transplantation?
Observational (n=20)
No
Are elevated serum pro-BNP levels and non-invasive parameters associated with acute rejection in patients who undergo cardiac transplantation?
Serum pro-BNP levels are significantly elevated in cardiac transplant recipients experiencing acute rejection and correlate with the severity of rejection, suggesting its potential utility as an adjunctive non-invasive biomarker.
Answers are grounded in this paper and cite their sources.
Should not yet alter rejection surveillance in heart transplant recipients; leaves open pro-BNP's role in future protocols.
Aim: Heart failure is a disease with high mortality and morbidity, reducing the patient's quality of life. Each year 10% of heart failure patients progress to end-stage heart failure. Cardiac transplantation is the gold standard treatment method in these patients, however acute rejection is the most important factor affecting the success of this treatment. In this study, it was aimed to evaluate endomyocardial biopsy results, serum pro-BNP and non-invasive parameters in patients with acute rejection following cardiac transplantation.Patients and Methods: Twenty patients who underwent cardiac transplantation in our center were included in the study. The patients were divided into two groups, namely acute rejection (n: 10) and without rejection (n: 10). Echocardiography, electrocardiography (ECG), endomyocardial biopsy results, serum reactive proteins (CRP), sedimentation rate and serum pro-BNP levels, were evaluated among the patients and compared between the groups.Results: Endomyocardial biopsies obtained from patients with acute rejection revealed grade 1 rejection in 6 (60%) patients, grade 2 in 3 (30%) patients and grade 3 rejection in 1 (10%) patients. CRP and sedimentation rate were found to be similar between the groups (p> 0.05). High pro-BNP levels were found in patients with rejection (4843.20 ± 6690.10 pg / ml) when compared to the control group (496.30± 216.20 pg / ml) (p: 0.001). In addition, higher pro-BNP levels were detected with progressing of rejection grade (p: 0.03). The highest pro-BNP level was found in a patient with Grade-3 rejection (15211 pg / ml, p: 0.000).Conclusion: Our results show that serum pro-BNP levels are associated with acute rejection. In addition, higher pro-BNP levels were found to be associated with advanced rejection levels.
No takes yet. Share an insight, caveat, or question.
Özgür Akkaya (2021) conducted an observational in Heart Transplantation (Acute Rejection) (n=20). Acute rejection vs. No rejection was evaluated on Serum pro-BNP levels (pg/ml) (p=0.001). Serum pro-BNP levels were higher in heart transplant patients with acute rejection compared to those without rejection, and levels increased with advanced rejection grades.
Synapse has enriched 10 related papers. Consider them for comparative context: